Nastech Pharmaceutical Company Inc. Q1 2008 Earnings Call Transcript
Matthew Haines - Senior Director of IR and Corporate Communications Stephen Quay - Chairman and CEO Gordon Brandt - President Bruce York - CFO Analysts Alex Quint - Quint Miller & Company Yale Jen - Maxim Group ...
Join the discussion below, or Read more at The Biotech Stock Blog.
Since: May 08
#1 Jun 1, 2008
Actors have scripts and stock companies have earnings call transcripts.
The company takes questions from analysts who have been following NSTK for years. The same analysts who gave ratings of outperform to high target prices, while the stock price has gone down
from $18 dollars per share to $1.19 today.
Shareholders are listening to one sided questions and answers. There is no fair balance when all parties involved in the transcript call have been friendly in their relationship for years.
The reality is that after 12 months of news releases, ratings by research firms, target call prices,star mine expert ratings releases, and even
assistance from a T.V. personalty expert, this stock has tanked big time. So is it their pipeline or
is it the most touted stock in history that has gone absolutely nowhere in 24 years?
Add your comments below
|MDRNA Announces Phase 2 Trial of PYY(3-36) Does... (Aug '08)||Oct '13||Marguerite||2|
|Nastech to Present at BMO Capital Markets Focus... (Nov '07)||Feb '12||khgkbkjj||2|
|Nascobal gel (Aug '11)||Aug '11||Judith Hladik-Voss||1|
|Nastech Pharma seeks to spin off subsidiary MDR... (Jul '08)||Jul '08||JIMMY T||1|
|Nastech plans to change its name (May '08)||May '08||JIMMY T||1|
|Nastech buyout coming soon (May '08)||May '08||news||1|
|Nastech raises $7.9M in stock sale; shares dive... (May '08)||May '08||JIMMY T||2|
Find what you want!
Search Nastech Pharmaceutical Company Forum Now
Copyright © 2017 Topix LLC